These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 21474673)
1. The small GTPase Rac1 is a novel binding partner of Bcl-2 and stabilizes its antiapoptotic activity. Velaithan R; Kang J; Hirpara JL; Loh T; Goh BC; Le Bras M; Brenner C; Clement MV; Pervaiz S Blood; 2011 Jun; 117(23):6214-26. PubMed ID: 21474673 [TBL] [Abstract][Full Text] [Related]
2. A feedforward relationship between active Rac1 and phosphorylated Bcl-2 is critical for sustaining Bcl-2 phosphorylation and promoting cancer progression. Chong SJF; Lai JXH; Qu J; Hirpara J; Kang J; Swaminathan K; Loh T; Kumar A; Vali S; Abbasi T; Pervaiz S Cancer Lett; 2019 Aug; 457():151-167. PubMed ID: 31103719 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide. Kang J; Chong SJ; Ooi VZ; Vali S; Kumar A; Kapoor S; Abbasi T; Hirpara JL; Loh T; Goh BC; Pervaiz S Oncotarget; 2015 Oct; 6(33):34191-205. PubMed ID: 26430964 [TBL] [Abstract][Full Text] [Related]
4. Decrease in intracellular superoxide sensitizes Bcl-2-overexpressing tumor cells to receptor and drug-induced apoptosis independent of the mitochondria. Clément MV; Hirpara JL; Pervaiz S Cell Death Differ; 2003 Nov; 10(11):1273-85. PubMed ID: 12894215 [TBL] [Abstract][Full Text] [Related]
5. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death. Shangary S; Johnson DE Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371 [TBL] [Abstract][Full Text] [Related]
6. Def-6, a guanine nucleotide exchange factor for Rac1, interacts with the skeletal muscle integrin chain alpha7A and influences myoblast differentiation. Samson T; Will C; Knoblauch A; Sharek L; von der Mark K; Burridge K; Wixler V J Biol Chem; 2007 May; 282(21):15730-42. PubMed ID: 17403664 [TBL] [Abstract][Full Text] [Related]
7. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment. Raghav PK; Verma YK; Gangenahalli GU Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216 [TBL] [Abstract][Full Text] [Related]
8. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277 [TBL] [Abstract][Full Text] [Related]
9. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Kolluri SK; Zhu X; Zhou X; Lin B; Chen Y; Sun K; Tian X; Town J; Cao X; Lin F; Zhai D; Kitada S; Luciano F; O'Donnell E; Cao Y; He F; Lin J; Reed JC; Satterthwait AC; Zhang XK Cancer Cell; 2008 Oct; 14(4):285-98. PubMed ID: 18835031 [TBL] [Abstract][Full Text] [Related]
10. Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor. Wu X; Zhang LS; Toombs J; Kuo YC; Piazza JT; Tuladhar R; Barrett Q; Fan CW; Zhang X; Walensky LD; Kool M; Cheng SY; Brekken R; Opferman JT; Green DR; Moldoveanu T; Lum L Nat Cell Biol; 2017 Oct; 19(10):1226-1236. PubMed ID: 28945232 [TBL] [Abstract][Full Text] [Related]
11. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways. Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656 [TBL] [Abstract][Full Text] [Related]
12. BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics. S Soderquist R; Eastman A Mol Cancer Ther; 2016 Sep; 15(9):2011-7. PubMed ID: 27535975 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of guanine nucleotide exchange and Rac-mediated signaling revealed by a dominant negative trio mutant. Debreceni B; Gao Y; Guo F; Zhu K; Jia B; Zheng Y J Biol Chem; 2004 Jan; 279(5):3777-86. PubMed ID: 14597635 [TBL] [Abstract][Full Text] [Related]
14. Sequence and helicity requirements for the proapoptotic activity of Bax BH3 peptides. Shangary S; Oliver CL; Tillman TS; Cascio M; Johnson DE Mol Cancer Ther; 2004 Nov; 3(11):1343-54. PubMed ID: 15542773 [TBL] [Abstract][Full Text] [Related]
15. Cell permeable BH3-peptides overcome the cytoprotective effect of Bcl-2 and Bcl-X(L). Vieira HL; Boya P; Cohen I; El Hamel C; Haouzi D; Druillenec S; Belzacq AS; Brenner C; Roques B; Kroemer G Oncogene; 2002 Mar; 21(13):1963-77. PubMed ID: 11960369 [TBL] [Abstract][Full Text] [Related]
16. Plant rac proteins induce superoxide production in mammalian cells. Hassanain HH; Sharma YK; Moldovan L; Khramtsov V; Berliner LJ; Duvick JP; Goldschmidt-Clermont PJ Biochem Biophys Res Commun; 2000 Jun; 272(3):783-8. PubMed ID: 10860831 [TBL] [Abstract][Full Text] [Related]
17. Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia. Iacovelli S; Ricciardi MR; Allegretti M; Mirabilii S; Licchetta R; Bergamo P; Rinaldo C; Zeuner A; Foà R; Milella M; McCubrey JA; Martelli AM; Tafuri A Oncotarget; 2015 Oct; 6(31):32089-103. PubMed ID: 26392332 [TBL] [Abstract][Full Text] [Related]
18. Antibody Binding to CD4 Induces Rac GTPase Activation and Alters T Cell Migration. Morillon YM; Lessey-Morillon EC; Clark M; Zhang R; Wang B; Burridge K; Tisch R J Immunol; 2016 Nov; 197(9):3504-3511. PubMed ID: 27694496 [TBL] [Abstract][Full Text] [Related]
19. BH3 domains as BCL-2 inhibitors: prototype cancer therapeutics. Letai A Expert Opin Biol Ther; 2003 Apr; 3(2):293-304. PubMed ID: 12662143 [TBL] [Abstract][Full Text] [Related]
20. MKK6 phosphorylation regulates production of superoxide by enhancing Rac GTPase activity. Harraz MM; Park A; Abbott D; Zhou W; Zhang Y; Engelhardt JF Antioxid Redox Signal; 2007 Nov; 9(11):1803-13. PubMed ID: 17854274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]